The results in GSE68468, GSE41258 revealed that the expression levels of CLU, SFTPD and CCL18 were particularly enhanced in CRC lung metastases compared with liver metastases (Fig. 4K-P). This evidence concerns the gene SFTPD and colorectal carcinoma.